R.grid
R.grid streamline clinical trial operations from months to minutes, increasing resources, efficiency, and engagement for clinical researchers. They offer an end-to-end clinical trial management system as well as a platform to ensure inclusive and scalable participation in clinical trials.
Medical research is a $2 trillion industry that is the backbone of drug discovery and medical device manufacturing. Institutions in the field spend $44 billion ($7billion by 2025) on manual processes like patient enrollment, trials, outcome analysis and reporting.
R.grid’s solutions help streamline the clinical trial management process, resulting in considerable savings in time and costs. Their Clinical Trial Management System supports study and trial planning, monitoring, and management in one accessible space, giving researchers the chance to build bespoke user-centric workflows and eliminate manual data re-entry. Their engagement platform, Inclusive, is designed to ensure inclusive and scalable trial participation. By bringing together clinical researchers, PPIE managers, coordinators, patient participants, underrepresented groups, and other stakeholders, R.grid help support community participation and long-term engagement throughout the research lifecycle.
Founder
Amber Hill
CEO
Amber holds a PhD in Biomedical Neuroscience from University College London. She has co-designed and implemented research impact programmes in the UK, Germany, the United States, China and Africa. Her work has been featured on The Lancet Neurology, and on BBC and ITV London.
Milestones
Founded at Entrepreneur First
Seed (£1 million) led by Ada Ventures
Seed ($6.5 million) led by Fuel Ventures